ADNA Trademark

Trademark Overview

On Friday, April 9, 2021, a trademark application was filed for ADNA with the United States Patent and Trademark Office. The USPTO has given the ADNA trademark a serial number of 90633823. The federal status of this trademark filing is REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED as of Thursday, January 2, 2025. This trademark is owned by TYRIS THERAPEUTICS, SLU. The ADNA trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines; Vaccine adjuvants; Vaccine preparations; Vaccine stabilizers; Therapeutic vaccines
adna

General Information

Serial Number90633823
Word MarkADNA
Filing DateFriday, April 9, 2021
Status654 - REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED
Status DateThursday, January 2, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesVaccines; Vaccine adjuvants; Vaccine preparations; Vaccine stabilizers; Therapeutic vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 16, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTYRIS THERAPEUTICS, SLU
Party Type10 - Original Applicant
Legal Entity Type13 - Limited Partnership
AddressMONCADA 46113
ES

Trademark Events

Event DateEvent Description
Tuesday, April 13, 2021NEW APPLICATION ENTERED
Friday, July 16, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 30, 2021ASSIGNED TO EXAMINER
Tuesday, December 7, 2021NON-FINAL ACTION WRITTEN
Tuesday, December 7, 2021NON-FINAL ACTION E-MAILED
Tuesday, December 7, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, April 8, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, April 12, 2022ASSIGNED TO LIE
Thursday, April 14, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 14, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 14, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, April 14, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, April 14, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 17, 2022LETTER OF SUSPENSION E-MAILED
Tuesday, May 17, 2022NOTICE OF SUSPENSION SENT - PENDING REVIEW
Thursday, December 29, 2022REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, March 16, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, December 8, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Monday, January 8, 2024REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, January 2, 2025REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

Related Keywords

adna vaccine vaccines therapeutic stabilizers adjuvants preparations